Presse

In diesem Bereich unserer Webseite finden Sie die neuesten nationalen und internationalen Pressemitteilungen der FERRING-Gruppe sowie eine Sammlung von Presseartikel über unsere innovativen Präparate aus den Bereichen Reproduktionsmedizin, Urologie, chronisch entzündliche Darmerkrankungen, Endokrinologie und Geburtshilfe.

Wenn Sie Journalist/-in sind und Fragen zu FERRING oder zu unseren Arzneimitteln haben, wenden Sie sich gerne direkt an uns:

Frau Dr. Sibille Engels 
FERRING Arzneimittel GmbH 
Tel.: +49 431 58 52 106 
Fax: +49 431 58 52 441 
E-Mail: info-service@ferring.de

Thursday, 30 August 2018

Ferring and Celmatix launch ambitious genomics collaboration to advance care in reproductive medicine and women’s health

Read press release

Monday, 02 July 2018

New analysis of Rekovelle^® data further supports use of AMH to personalise fertility treatment

Read press release

Wednesday, 27 June 2018

Ferring’s heat-stable carbetocin could save thousands of women’s lives by preventing excessive bleeding after childbirth

Read press release

Thursday, 03 May 2018

Ferring signs global agreement to commercialise novel gene therapy for bladder cancer patients

Read press release

Thursday, 05 April 2018

Ferring acquires innovative biotechnology company and microbiome pioneer Rebiotix Inc.

Read press release

Friday, 16 March 2018

Nocturia: the most common cause of a poor night’s sleep¹, say experts on World Sleep Day

Read press release

Thursday, 15 March 2018

Ferring announces positive outcome of European Decentralised Procedure (DCP) for Testavan^®, a treatment for men with hypogonadism

Read press release

Wednesday, 07 March 2018

March of Dimes and Ferring announce new Prematurity Research Center at Imperial College London

Read press release

Thursday, 22 February 2018

Ferring Pharmaceuticals and MSD Announce Completion of Largest Clinical Trial Ever Conducted in Postpartum Haemorrhage

Read press release

Wednesday, 14 February 2018

Ferring announces 30 million CHF investment in new biotech centre in Switzerland

Read press release

Friday, 26 January 2018

Ferring Announces Recipients of Innovation Grants Program 2017-2018

Read press release

Monday, 22 January 2018

Ferring enters into worldwide OmniAb^® platform license agreement with Ligand

Read press release

VITAROS^®

 Weiter zur Pressemitteilung

Bildmaterial

Logo FERRING Arzneimittel

Download als JPG

Logo FERRING GmbH

Download als JPG

Haben Sie Fragen?

Schreiben Sie uns einfach an info-service@ferring.de.

FERRING – für Sie da.